Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Jun 3, 2010

Premium

Daniel Anderson, Charles Cooney, and Robert Langer have joined the scientific advisory board of Alnylam Biotherapeutics, a division of Alnylam Pharmaceuticals.

Anderson is a faculty member in the department of chemical engineering at the Massachusetts Institute of Technology's Division of Health Science Technology and the David H. Koch Institute for Integrative Cancer Research at MIT.

Cooney is the Robert T. Haslam professor of chemical and biochemical engineering and faculty director for the Deshpande Center for Technological Innovation at MIT. He is currently a director of Polypore International and Biocon, a principal at BioInformation Associates, and a director of Genzyme.

Langer is the David H. Koch Institute Professor at MIT and a member of the Institute of Medicine, the National Academy of Engineering, and the National Academy of Sciences.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.